Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

ALS Patient Treated with Medical Marijuana Outlives Anti-Marijuana Doctors

Monday, November 21, 2016 13:15
% of readers think this story is Fact. Add your two cents.

(Before It's News)

November 22nd, 2016

By Ryan Cristián

Guest writer for Wake Up World

Over thirty years ago, a woman named Cathy Jordanwas diagnosed with ALS (Amyotrophic Lateral Sclerosis) also known as Lou Gehrig’s disease. In 1986 she was given 3 to 5 years to live. At a time when marijuana was in no way recognized as a valid medical treatment, and with no other treatments to rely on, she put her hope in marijuana. Every doctor she spoke with was outraged with this decision. Today Cathy is alive and thriving while most of the doctors with whom she spoke are not.  

SJordan28e.jpg

“All my docs are retiring or dead. I’ve outlived 5 support groups and 4 neurologists,” Cathy told Americans for Safe Access’ Jahan Marcu.

ALS is characterized by the death of motor neurons leading to loss of limb control, breathing, swallowing, speech and widespread cellular dysfunction. “Most people start using a feeding tube because they are afraid of choking to death”, says Cathy. Mrs. Jordan began using cannabis from a Florida grower to treat her ALS in the late 80’s. “Donny Clark provided my medicine, grown in the Myakka River Valley… he was busted and sentenced to life in prison, and that strain of cannabis was lost.”

CONTINUE READING:

Recommended articles by Ryan Cristián:

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.